Tech Company Financing Transactions
Tetra Discovery Partners Funding Round
Tetra Discovery Partners closed a $1 million Seed venture capital round on 10/2/2013. Investors included Biosciences Research and Commercialization Center, Grand Angels and Michigan Economic Development Corporation.
Transaction Overview
Company Name
Announced On
10/2/2013
Transaction Type
Venture Equity
Amount
$1,041,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to develop an innovative drug to treat cognitive impairment caused by Alzheimer's disease, and a second drug to treat depression and restore cognitive function in patients who have suffered traumatic brain injury (TBI).
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
38 Fulton St. W 303
Grand Rapids, MI 49503
USA
Grand Rapids, MI 49503
USA
Phone
Website
Email Address
Overview
Our research focuses on developing new treatments for depression based on subtype-selective modulation of phosphodiesterase 4B (PDE4B). PDE4 in neurons is responsible for the hydrolysis of cAMP. We and our colleagues recently described the protein structure of a key PDE4 regulatory domain known as UCR2.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Gurney
Chief Financial Officer
Harvey Elgersma
Chief Medical Officer
Scott Reines
VP - Bus. Development
Joseph Collard
VP - Regulatory Affairs
Chad Coberly
Browse more venture capital transactions:
Prev: 10/2/2013: Skura venture capital transaction
Next: 10/2/2013: BioNano Genomics venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document tech company VC transactions. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs